Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?

作者: H. J. McKenna

DOI: 10.1007/S002620050576

关键词:

摘要: flt3 ligand (FL) is a growth factor that induces hematopoietic progenitor cell and dendritic (DC) expansion when administered to mice. Lymphoid-related (CD8α+) myeloid-related (CD8α−) DC are transiently expanded in multiple tissues. Treatment of tumor-bearing mice with FL results slower tumor and, some cases, rejection the development tumor-specific T immunity. The clinical use as cellular vehicles for antigen presentation generate response under investigation. currently generated ex vivo, pulsed antigen, then infused into patients, much effort being directed toward optimizing each these steps. Administration humans profound increase circulating DC. availability large number vivo has important implications immunotherapy approaches.

参考文章(59)
Volker L. Reichardt, Craig Y. Okada, Arcangelo Liso, Claudia J. Benike, Keith E. Stockerl-Goldstein, Edgar G. Engleman, Karl G. Blume, Ronald Levy, Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility Study Blood. ,vol. 93, pp. 2411- 2419 ,(1999) , 10.1182/BLOOD.V93.7.2411
Stewart D. Lyman, Sten Eirik W. Jacobsen, c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood. ,vol. 91, pp. 1101- 1134 ,(1998) , 10.1182/BLOOD.V91.4.1101
Aniruddha Choudhury, James L. Gajewski, Jan C. Liang, Uday Popat, David F. Claxton, Kay-Oliver Kliche, Michael Andreeff, Richard E. Champlin, Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Blood. ,vol. 89, pp. 1133- 1142 ,(1997) , 10.1182/BLOOD.V89.4.1133
SD Lyman, L James, L Johnson, K Brasel, P de Vries, SS Escobar, H Downey, RR Splett, MP Beckmann, HJ McKenna, Cloning of the human homologue of the murine flt3 ligand : a growth factor for early hematopoietic progenitor cells Blood. ,vol. 83, pp. 2795- 2801 ,(1994) , 10.1182/BLOOD.V83.10.2795.2795
Kenneth Brasel, Hilary J. McKenna, Keith Charrier, Phillip J. Morrissey, Douglas E. Williams, Stewart D. Lyman, Flt3 Ligand Synergizes With Granulocyte-Macrophage Colony-Stimulating Factor or Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Progenitor Cells Into the Peripheral Blood of Mice Blood. ,vol. 90, pp. 3781- 3788 ,(1997) , 10.1182/BLOOD.V90.9.3781
Adrian A. Maung, Nikola L. Vujanovic, Raymond J. Steptoe, Angus W. Thomson, Samuel G. Shaw, Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy Journal of Immunology. ,vol. 161, pp. 2817- 2824 ,(1998)
Hal E. Broxmeyer, Christie M. Traycoff, Stewart Lyman, George Sledge, Yi Fan, Kenneth Cornetta, Keyue Chen, Stephen Braun, Jay Gaddy, Eric A. Wiebke, Antitumor Activity and Immunotherapeutic Properties of Flt3-Ligand in a Murine Breast Cancer Model Cancer Research. ,vol. 57, pp. 3511- 3516 ,(1997)
Rik Derynck, Michael A. Palladino, Alfredo R. Lopez, Nancy Gillett, Irene Figari, Hsun-Lang Chang, Increased Transforming Growth Factor β Expression Inhibits Cell Proliferation in Vitro, yet Increases Tumorigenicity and Tumor Growth of Meth A Sarcoma Cells Cancer Research. ,vol. 53, pp. 4391- 4398 ,(1993)
A. O'garra, S. E. Macatonia, K. M. Murphy, P. Vieira, N. A. Hosken, M. Wysocka, Chyi-Song Hsieh, M. Litton, J. A. Culpepper, G. Trinchieri, Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. Journal of Immunology. ,vol. 154, pp. 5071- 5079 ,(1995)
G Akabani, M A Morse, D Coleman, H K Lyerly, N Niehaus, R E Coleman, Migration of Human Dendritic Cells after Injection in Patients with Metastatic Malignancies Cancer Research. ,vol. 59, pp. 56- 58 ,(1999)